WILMINGTON, DE — Incyte (Nasdaq: INCY) announced that it will release its third quarter 2025 financial results before markets open on Tuesday, October 28, 2025. The company will host a conference call and live webcast to discuss the results and provide a business update at 8:00 a.m. Eastern Time the same day.
The earnings release will be available at 7:00 a.m. ET, followed by the investor call an hour later. Participants in the U.S. can dial 877-407-3042 to join the call, while international participants may use 201-389-0864. The conference ID number is 13756261. A replay of the call will remain accessible for thirty days at 877-660-6853 (U.S.) or 201-612-7415 (international), using the same conference ID. The webcast, including presentation slides, can be accessed at Investor.Incyte.com and will be archived for ninety days.
Headquartered in Wilmington, Delaware, Incyte is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for patients with serious diseases. Its portfolio spans oncology and inflammation and autoimmunity, supported by a growing pipeline and international operations across North America, Europe, and Asia.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.